|
M-1524 - Recursive Partitioning Analysis of CYP51A Mutations for Refinement of Epidemiological Cutoff Values (ECV) of Azoles and A. fumigatus (AF) (click for details) |
|
|
|
F1-1378 - In Vitro Activity of E1210 and In Vivo Activity of E1211: A Water-Soluble Prodrug of E1210 in Combination with Other Antifungals (click for details) |
|
|
|
Title:
M-299 - Proangiogenic Growth Factors Act Synergistically with Amphotericin B (AmB) to Reduce Mortality in Experimental Invasive Pulmonary Aspergillosis (IPA) (click for details) |
|
|
|
Title:
F1-1382 - In Vitro Synergistic Fungicidal Activity of Tricyclazole (TCZ) and Tropolone (TRO) in Combination with Voriconazole (VCZ) against VCZ-Resistant (R) Aspergillus flavus. (click for details) |
|
|
|
M-286 - Early Posaconazole (POS) Prophylaxis During the First 100 Days in Allogeneic Hematopoietic Cell Transplant (HCT) Recipients: A Single Center Experience (click for details) |
|
|
|
A2-584 - Efficacy and Pharmacodynamic of Voriconazole combined with Anidulafungin in azole resistant invasive aspergillosis (click for details) |
|
|
|
M-1528 - Emergence of Voriconazole Resistance Due to a New Resistance Mechanism in Clinical and Non-Clinical Aspergillus fumigatus Isolates in the Netherlands in 2010 (click for details) |
|
|
|
D-672 - A Multi-Site Evaluation to Determine the Performance of the Sensititre YeastOne Susceptibility System using the Sensititre Vizion Compared to a Mirror Read Method (click for details) |
|
|
|
F1-1389 - Redirected Specificity of T cells to Target Aspergillus (click for details) |
|
|
|
A2-579 - In-vivo Pharmacodynamic (PD) Target for the Oral Glucan Synthase Inhibitor (GSI), MK-3118 (MK) Against C. albicans (CA), C. glabrata (CG), and C. parapsilosis (CP) in the Neutropenic Murine Disseminated Candidiasis Model (click for details) |
|
|
